Snowball logo
logo
TSHA_logo

Taysha Gene Therapies, Inc

TSHA โ€ข NASDAQ
$6.33-$0.06ย  (0.94%)

Frequently asked questions

What sector does Taysha Gene Therapies, Inc (TSHA) operate in?

Taysha Gene Therapies, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Taysha Gene Therapies, Inc (TSHA) current stock price?

As of the latest data, Taysha Gene Therapies, Inc stock price is $6.33, with a previous close of $6.39. Taysha Gene Therapies, Inc lost -$0.06 in the last trading session, representing a -0.94% loss.

What is Taysha Gene Therapies, Inc (TSHA) current market capitalization?

Taysha Gene Therapies, Inc market cap is approximately 1.82 billion.

What is Taysha Gene Therapies, Inc (TSHA) Earnings Per Share (EPS)?

The trailing EPS is -$0.34, and the forward EPS is -$0.41.

What is Taysha Gene Therapies, Inc (TSHA) EBITDA?

Taysha Gene Therapies, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -28.00 million.

Does Taysha Gene Therapies, Inc (TSHA) pay dividends?

No. Taysha Gene Therapies, Inc does not pay a dividend.

How did Taysha Gene Therapies, Inc (TSHA) perform in its most recent earnings report?

In the last report (December 31, 2025), Taysha Gene Therapies, Inc posted an EPS surprise of 23.43% and a revenue surprise of -12.95%.

When is Taysha Gene Therapies, Inc (TSHA) next earnings report?

Taysha Gene Therapies, Inc is expected to release its next earnings report on March 31, 2026.

What is Taysha Gene Therapies, Inc (TSHA) beta (volatility) score?

Taysha Gene Therapies, Inc has a beta of 1.079, meaning its volatility is roughly in line with the market.